SCHEMBL13499191

SCHEMBL13499191

c1cc(C2CCCN2)ccc1CN1CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.56
HRH4 Q9H3N8 1/20 0.51
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 2/20 0.50
CXCR4 P61073 3/20 0.49
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
ADRA2C P18825 1/20 0.45
CCR2 P41597 1/20 0.45
CXCL12 P48061 1/20 0.45
BLM P54132 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MBTD1 Q05BQ5 1/20 0.45
L3MBTL3 Q96JM7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13499189 0.95 HRH3 (0.55) HRH3HRH4ALDH1A1KDM4ECXCR4
SCHEMBL8219730 0.82 SMN1; SMN2 (0.50) HRH3ALDH1A1KDM4ECYP2D6CYP2C19
SCHEMBL8212158 0.81 PRMT6 (0.49) ALDH1A1KDM4ECYP2D6CYP2C19TDP1
SCHEMBL13499190 0.79 SMN1; SMN2 (0.49) HRH3ALDH1A1KDM4ECYP2D6CYP2C19
SCHEMBL8221503 0.78 PRMT6 (0.45) ALDH1A1KDM4ECYP2D6CYP2C19MEN1
SCHEMBL5802040 0.76 HRH3 (0.44) HRH3HRH4ALDH1A1KDM4ECXCR4
SCHEMBL13577677 0.76 HRH3 (0.69) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL4277270 0.75 HRH3 (1.00) HRH3HRH4ALDH1A1KDM4ECYP2D6
SCHEMBL1936159 0.75 CXCR4 (0.57) HRH3HRH4ALDH1A1KDM4ECXCR4
SCHEMBL7319627 0.75 HRH3 (0.67) HRH3HRH4ALDH1A1KDM4ECYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662811-B2 N-(((5R)-5-((1-methylethyl)amino)-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-2-((2R)-1-((4-methylphenyl)sulfonyl)-3-oxo-1,2,3,4-tetrahydro-2-pyrazinyl)acetamide; for treatment of pain and diseases, such as inflammation mediated diseases AMGEN INC. (US) 2010-02-16 US disclosed
US-7662811-B2 N-(((5R)-5-((1-methylethyl)amino)-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-2-((2R)-1-((4-methylphenyl)sulfonyl)-3-oxo-1,2,3,4-tetrahydro-2-pyrazinyl)acetamide; for treatment of pain and diseases, such as inflammation mediated diseases AMGEN INC. (US) 2010-02-16 US disclosed